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Background: Preproinsulin signal peptide mutations have been linked to human diabetes.
Results: Preproinsulin mutants fail to be fully translocated across the endoplasmic reticulum membrane, accumulate in the
cytosol, and lead to  cell death.
Conclusion: Cytosolic preproinsulin accumulation contributes to  cell failure.
Significance:This reveals a novel pathogenesis of diabetes associated with inefficient preproinsulin translocation and cytosolic
accumulation.
Among the defects in the early events of insulin biosynthesis,
proinsulin misfolding and endoplasmic reticulum (ER) stress
have drawn increasing attention as causes of cell failure. How-
ever, no studies have yet addressed potential defects at the cyto-
solic entry point of preproinsulin into the secretory pathway.
Here, we provide the first evidence that inefficient translocation
of preproinsulin (caused by loss of a positive charge in the n
region of its signal sequence) contributes to  cell failure and
diabetes. Specifically, we find that, after targeting to the ER
membrane, preproinsulin signal peptide (SP) mutants associ-
atedwith autosomal dominant late-onset diabetes fail to be fully
translocated across the ER membrane. The newly synthesized,
untranslocated preproinsulin remains strongly associated with
the ERmembrane, exposing its proinsulinmoiety to the cytosol.
Rather than accumulating in the ER and inducing ER stress,
untranslocated preproinsulin accumulates in a juxtanuclear
compartment distinct from the Golgi complex, induces the
expression of heat shock protein 70 (HSP70), and promotes 
cell death. Restoring an N-terminal positive charge to the
mutant preproinsulin SP significantly improves the transloca-
tion defect. These findings not only reveal a novel molecular
pathogenesis of  cell failure and diabetes but also provide the
first evidence of the physiological and pathological significance
of the SP n region positive charge of secretory proteins.
In pancreatic  cells, insulin biosynthesis begins within the
cytosol, where insulin mRNA is translated into the precursor
preproinsulin. Preproinsulin comprises, sequentially, signal
peptide (SP),6 insulin B chain, C peptide, and A chain (1, 2). To
enter the secretory pathway, nascent preproinsulin is delivered
by the signal recognition particle (SRP) to the endoplasmic
reticulum (ER) membrane, where preproinsulin is translocated
to the luminal side of the ER and cleaved by signal peptidase,
forming proinsulin (3, 4). Within the oxidizing environment of
the ER lumen, proinsulin undergoes rapid oxidative folding,
forming three evolutionarily conserved disulfide bonds (5–8).
Among these early events, proinsulin misfolding in the ER
lumen and the consequent ER stress have been shown to play an
important role in the autosomal dominant syndrome ofmutant
insulin (INS) gene-induced diabetes of youth (MIDY) (9–13).
However, no studies have addressed earlier defects at the point
of entry of preproinsulin into the ER. Recently, two preproin-
sulin SP mutants, preproinsulin R6C and R6H (here simply
called R6C or R6H) have been linked to autosomal dominant
late-onset diabetes in humans (14–16). The molecular mecha-
nism by which these mutants bring about diabetes has been
speculated to involve ER stress (14), but the actual defect has
remained unknown.
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Like other secretory proteins targeted to the ER lumen, pre-
proinsulin SP has three distinct regions: a positively charged “n
region,” a central hydrophobic “h region,” and a “c region” con-
taining the signal peptidase cleavage site. Mutations R6C and
R6H eliminate the highly conserved n region positive charge,
which forms the basis for the “positive-inside” rule that is
thought to facilitate SP orientation at the ERmembrane during
membrane protein translocation (17–19). Nevertheless, to
date, no human disease has been shown to be caused by a loss of
the n region positive charge. Indeed, a recent study reported
that neither R6C nor R6H results in defective insulin granule
targeting of a preproinsulin-GFP chimera, thus leaving the dia-
betes linked to these mutations largely unexplained (14).
Here we demonstrate that, upon targeting to the ER mem-
brane, preproinsulin R6C and R6H fail to be fully translocated
across the ER membrane. The newly synthesized untranslo-
cated preproinsulin remains strongly associated with the ER
membrane, exposing its proinsulin moiety to the cytosol.
Untranslocated preproinsulin accumulates in a juxtanuclear
cytoplasmic compartment distinct from the Golgi complex,
induces the expression of heat shock protein 70 (HSP70), and
leads to  cell death. Restoring the N-terminal positive charge
of mutant preproinsulin SP significantly improves the translo-
cation defect. This study reveals a novel mechanism leading to
 cell failure and diabetes and highlights the pathological con-
sequences of loss of the SP n region positive charge of secretory
proteins.
EXPERIMENTAL PROCEDURES
Materials—Guinea pig anti-porcine insulin antibody and the
human insulin-specific RIA kit (catalog no. HI-14 K) was from
Millipore. Rabbit anti-Myc and anti-GFP antibodies were from
Immunology Consultant Laboratories. Anti-GM130 antibody
was from BD Biosciences. Anti-calnexin antibody was from
Enzo Life Sciences. Zysorbin was from Zymed Laboratories
Inc.. 35S-amino acid mixture (Met  Cys) and pure [35S]Met
were from PerkinElmer Life Sciences. DTT, protein A-agarose,
digitonin, N-ethylmaleimide, brefeldin A, and MG132 were
from Sigma-Aldrich. Peptide-N-glycosidase F (PNGaseF) was
from New England Biolabs. 4–12% NuPage gel, Met/Cys-defi-
cient DMEM, and all other tissue culture reagents were from
Invitrogen. The INS1 r9 cells were from Dr. Claes B. Wollhein
(University of Geneva, Switzerland).
Human Islet Study—Institutional review board approval for
research use of isolated human islets was obtained from the
University ofMichigan. Human islets were isolated from previ-
ously healthy, nondiabetic organ donors by the University of
Chicago Transplant Center. Three independent human islet
batches from two male donors aged 20 and 58 and one female
donor aged 48 were used in this study. The islets were divided
into two groups incubated in CMRLmedium (Invitrogen) con-
taining either 5.5 or 25.5 mM glucose for 20 h before metabolic
radiolabeling with either [35S]Met/Cys mixtures or pure
[35S]Met, as indicated, for 10 min. Normalized by DNA, the
islet lysates were immunoprecipitated using anti-insulin and
analyzed as indicated in the figure legends.
Mutagenesis, Cell Culture, Transfection, Metabolic Labeling,
and Immunoprecipitation—Human and mouse preproinsulin
mutants were generated using a site-directed mutagenesis kit
(Agilent). INS1 rat  cells, Min6 mouse  cells, or 293T human
embryonic kidney cells were plated onto 12-well plates 1 day
before transfection with Lipofectamine 2000 (Invitrogen) using
1–2 g of plasmid DNA. 48 h after transfection, cells were
pulse-labeled with [35S]Met/Cys or pure [35S]Met with or with-
out chase as indicated. Cells used for analysis of (pre)proinsulin
oxidative folding were preincubated with 20 mM N-ethylma-
leimide in PBS on ice for 10 min before lysis. Immunoprecipi-
tation and non-reducing or reducing Tris-Tricine urea SDS-
PAGE analyses were performed as described previously (5, 13).
For Western blotting, 20 g of total protein lysates was boiled
in SDS sample buffer with or without 100mMDTT, resolved by
4–12% NuPage, electrotransferred to nitrocellulose, and blot-
ted with appropriate first antibodies, followed by appropriate
secondary antibodies conjugated with HRP, with development
by enhanced chemiluminescence. The BiP promoter-driven
firefly luciferase assay for Min6 cells was performed as
described previously (9).
In Vitro Targeting and Translocation Study—The cotransla-
tional protein targeting and translocation assay has been
described previously in detail (20, 21). Briefly, wheat germ
translation extract, free of endogenous SRP and SRP receptor,
was used to synthesize WT and mutant preproinsulin in the
presence of [35S]Met (for the in vitro assay,methionine residues
were added to the C terminus of preproinsulin). To best mimic
a single round of cotranslational protein targeting, a cap analog,
7-methyl-GTP, was added 1–2 min after translation initiation
to inhibit additional rounds of synthesis. Purified SRP, SRP
receptor, and ER microsomal membranes in which the endog-
enous SRP and SRP receptor had been removed by high-salt
wash and partial trypsin digestion were then added within 1
min. Translationwas continued for 20–30min at 26 °C to allow
completion of preproinsulin synthesis, at which point the reac-
tions were stopped and analyzed. The targeting and transloca-
tion efficiency was assessed by two approaches (cleavage of the
signal sequence and protection of proinsulin from proteinase K
digestion) and analyzed by SDS-PAGE and autoradiography.
The localization of preproinsulin and proinsulin was assessed
using a sedimentation assay. The targeting and translocation
reactions were carried out as described in the previous para-
graph. A 30-l reactionmixture was layered onto a 50-l cush-
ion of 0.5 M sucrose and ultracentrifuged at 55,000 rpm at 4 °C
for 5 min (TLA100, Beckman Coulter). The supernatant was
TCA-precipitated. This and the microsomal pellet were dis-
solved and analyzed on SDS-PAGE.
Selective Plasma Membrane Permeabilization by Digitonin,
Proteinase K Digestion, and Sodium Carbonate Extraction—
For the ER targeting experiments, after labeling with [35S]Cys/
Met, the plasmamembranes of 293T cells transfected with pre-
proinsulin WT or mutants were partially permeabilized with
0.01% digitonin as described previously (13). For proteinase K
(PK) digestion, 2 days after transfection, 293T cells expressing
Myc-tagged R6C or A24D were incubated on ice with either
PBS only, PBS plus 0.01% digitonin and 10 g/ml PK, or PBS
plus 1% Triton X-100 and 10 g/ml PK for 30 min. 2 M PMSF
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and SDS sample buffer were added, boiled, and analyzed by
Western blotting using anti-Myc antibody. For sodium carbon-
ate extraction, after pulse-labeling with [35S]Met/Cys, trans-
fected cells were suspended in 0.1 M sodium carbonate (pH 12),
homogenized, and incubated on ice for 1 h, followed by sedi-
mentation at 50,000 rpm at 4 °C for 1 h. The supernatants and
pellets were collected and immunoprecipitated with anti-Myc,
anti-calnexin, and anti-PDI antibodies.
Generation of Inducible  Cell Lines Expressing Mouse Ins2
Wild-type, R6C, and A24D; Cell Proliferation; and Cell Death
Assay—The INS-r9 cells carrying the reverse tetracycline/
doxycycline-dependent transactivator (22) were cotransfected
with a puromycin resistance plasmid and pTRE plasmids
encodingMyc-taggedmouse Ins2WT,R6C, orA24D. Puromy-
cin-resistant clones were isolated and tested for the expression
ofMyc-tagged preproinsulinWTor R6C by both pulse labeling
andWestern blotting after induction with 2g/ml doxycycline
(Dox). For determining cell proliferation, 3000 cells of induc-
ible clones were seeded into 96-well plates and incubated with
or without 2 g/ml Dox for 4 days. BrdU incorporation was
measured using a BrdU cell proliferation kit (Millipore). For
examining cell death, the cells of inducible clones were seeded
into 8-well chamber slides (LabTek) and incubated with or
without 2g/mlDox for 4 days. Cell apoptosiswasmeasured by
labelingDNA strand breaks (TUNEL) using an in situ cell death
detection kit (Roche) with DAPI counterstaining to identify the
nuclei. A total of more than 4500 cells expressing the wild type
or R6C were counted from three independent experiments.
Confocal Imaging—INS1-inducible cell lines expressing
mouse preproinsulinWT, R6C, and A24Dwere induced with 2
g/mlDox for 4 days. The cellswere preincubatedwith 5g/ml
cycloheximide for 1 h, followed by either permeabilization with
0.01% digitonin on ice for 3 min (selectively permeabilizing the
plasmamembrane) or with 0.5% Triton X-100 (fully permeabi-
lizing all membranes), as indicated. The cells were then fixed
with formaldehyde, blocked, and stained with anti-Myc, anti-
PDI (an ER marker), and anti-GM130 (a Golgi marker), fol-
lowed by secondary antibodies conjugated to fluorophores, and
imaged by epifluorescence in an Olympus FV500 confocal
microscope with a 60 oil objective. For disrupting the Golgi
structure (23), the cells were pretreated with 5 M brefeldin A
for 30 min before permeabilization with 0.01% digitonin for 3
min.
Statistical Analyses—Statistical analyses were carried out by
analysis of variance followed by Newman-Keuls multiple com-
parison test using GraphPad Prism 6. p 0.05 was considered
to be statistically significant.
RESULTS
R6C/R6HCauses Early Defects in Preproinsulin to Proinsulin
Conversion—We developed a method that could specifically
distinguish processed and unprocessed human preproinsulin
(13). Because human preproinsulin has two methionines in the
SP and six cysteines in the proinsulin moiety (Fig. 1A, top
panel), pure [35S]Met labels exclusively unprocessed preproin-
sulin, whereas a [35S]Met/Cys mixture labels both preproinsu-
lin and proinsulin. Using this method, we first examined the
processing of preproinsulin to proinsulin of newly synthesized
preproinsulinWT andmutants in transfected 293T cells. Com-
pared with the WT, R6C exhibited significantly more unpro-
cessed preproinsulin labeled by [35S]Met (Fig. 1A, bottom pan-
el; preproinsulin-A24D, which is defective in SP cleavage,
serves as a positive control of uncleaved preproinsulin (13)).
After a 90-min chase, although the modest fraction of proinsu-
lin derived from R6C was secreted with normal efficiency,
unprocessed preproinsulin R6C largely disappeared without
conversion to proinsulin (Fig. 1B). The defect of R6H was sim-
ilar to that of R6C but less severe.
To examine whether unprocessed R6C and R6H were
exposed to the ER lumen, we analyzed newly synthesized pre-
proinsulin using Tris-Tricine urea SDS-PAGE under both non-
reducing and reducing conditions. Unlike proinsulin and
uncleaved A24D, which underwent oxidative folding in the ER
lumen (13), unprocessed R6C and R6H remained as fully
reduced forms (Fig. 1C), suggesting that their proinsulinmoiety
is not exposed to the oxidizing environment of the ER lumen.
Because a small fraction of unprocessed preproinsulin WT
was observed in transfected 293T cells (Fig. 1, A–C and F), we
decided to evaluate the translocation/processing efficiency of
wild-type preproinsulin in primary  cells. After 10 min of
labeling of isolated human pancreatic islets, 10% of the spe-
cific immunoprecipitable product remained as unprocessed
preproinsulin, as demonstrated by specific labeling of this band
with pure [35S]Met (Fig. 1D), by comigration of this band on
SDS-PAGE with SP cleavage-defective A24D (Fig. 1E), and by
its enhanced intensity upon stimulation with high glucose (Fig.
1,D–E). Unprocessed preproinsulinWTwas reduced fully (Fig.
1E), suggesting that, in normal human islets, some fully trans-
lated preproinsulinmolecules are present in the cytosol prior to
entry into the oxidizing environment of the ER lumen.
R6C Is Targeted to and Strongly Associated with the ERMem-
brane but Exhibits Impaired Polypeptide Translocation—Mu-
tations of Arg-6 eliminate a highly conserved n region positive
charge, which is generally thought to be important for the tar-
geting and translocation of secretory and membrane proteins
(18, 24–27). To determine whether R6C affects these early
steps during insulin biosynthesis, we first tested the SRP-de-
pendent targeting and translocation ofWTandmutant prepro-
insulins into ER microsomal membranes in a reconstituted in
vitro assay (20). Analysis of the reaction on the basis of both SP
cleavage (Fig. 2A) and sensitivity to PK digestion (Fig. 2B) dem-
onstrated that R6C mutation caused a 2-fold reduction in the
efficiency of targeting and translocation of preproinsulin.
To uncouple the effects of targeting from translocation
across the ER, we performed a sedimentation analysis to exam-
ine the localization of preproinsulin and proinsulin after the
targeting/translocation reaction was completed. As expected,
in the absence of SRP, only a small fraction of preproinsulinwas
associatedwith themicrosomalmembrane, and the presence of
SRP significantly increased the amount of proinsulin mole-
cules, which were primarily associated with the microsome.
Unexpectedly, in the presence of SRP, the majority of prepro-
insulin R6C also became microsome-bound (Fig. 2, C and D).
This suggests that R6C was targeted to the ER and that the
mutation affected its translocation across the ER membrane.
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To test this notion, we examined the localization of R6C in
living cells. We coexpressed preproinsulin WT or R6C with a
separate CMV promoter-driven GFP expressed in the cytosol
of transfected 293Tcells. The plasmamembranewas selectively
permeabilized with 0.01% digitonin, and cytosolic proteins
were separated from organelle-bound proteins by centrifuga-
tion (13). Although most cytosolic GFP shifted to the superna-
tant in digitonin-treated cells, both uncleaved and cleaved R6C
remained exclusively in the pellet (Fig. 2E), consistent with the
results from in vitro assays (Fig. 2C). To examine the extent of
membrane engagement of R6C, we employed a sodium carbon-
ate wash, which separates luminal and peripheral membrane
proteins from integral membrane proteins (28). As shown in
Fig. 2F, processed proinsulin derived from R6C was fully
extracted along with the ER luminal component BiP, whereas
the majority of uncleaved preproinsulin R6C (or A24D)
remained in the membrane fraction along with the ER mem-
brane protein calnexin. These results provide strong evidence
that the newly synthesized R6C was targeted to the ER mem-
brane and became organelle-bound.
To examine the topology of R6C on the ER membrane, we
performed PK digestion after permeabilization of the plasma
membranewith digitonin (13). In digitonin-permeabilized cells
(Fig. 3A, DIG), preproinsulin A24D (a mutant known to be
translocated efficiently translocated (13)) was demonstrably
resistant to PK digestion (Fig. 3A, right panel). By contrast,
although proinsulin derived from R6C also resisted PK diges-
tion in digitonin-permeabilized cells, unprocessed R6C was
fully digested (Fig. 3A, left panel), indicating that unprocessed
R6C was exposed on the cytosolic side of the ER membrane.
Both R6C and A24D were fully digested when the ER mem-
brane was permeabilized with 1% Triton X-100 (Fig. 3A, TRX).
To independentlymonitor the translocation of preproinsulin
into the ER lumen, we engineered two preproinsulins with
potential N-linked glycosylation sites located either at residue
18 of the C peptide (Fig. 3B, top panel, A(Cpep18)N) or at resi-
due 5 of the insulinB chain (Fig. 3B, top panel,H(B5)T). Exploit-
ing the fact that pure [35S]Met labels preproinsulin but not pro-
insulin (Fig. 1A), we found that proinsulin derived from R6C
became glycosylated (confirmed by deglycosylation with pep-
FIGURE 1. The early events of insulin biosynthesis and defects in processing of preproinsulin to proinsulin caused by R6C or R6H. A, human preproin-
sulin has two methionines in its SP and six cysteines in its proinsulin moiety (top panel). 293T cells transfected with plasmids encoding preproinsulin WT or
mutants were labeled with either [35S]Met/Cys or [35S]Met for 10min. The cell lysates were immunoprecipitated with anti-insulin and analyzed using NuPage
under reducing conditions. Pure [35S]Met labels only unprocessed human preproinsulin (preProins), whereas [35S]Met/Cys labels both human preproinsulin
and proinsulin (Proins). Con, control. B, 293T cells transfected with empty vector (EV) or plasmids encoding preproinsulin WT or mutants were labeled with
[35S]Met/Cys for 10 min followed by 0- or 90-min chase. Cell lysates (C) and chase media (M) were analyzed as in A. C, the newly synthesized preproinsulin WT
andmutants from transfected293T cellswere labeledwith [35S]Met/Cys for 10min, immunoprecipitated, andanalyzedusingTris-Tricineurea SDS-PAGEunder
non-reducing and reducing conditions. The asteriskdenotes oxidized uncleavedA24D.D, human islets preincubatedwith 5.5 or 25.5mMglucose for 20 hwere
labeled with either [35S]Met/Cys or [35S]Met for 10 min. The islet lysates were immunoprecipitated with anti-insulin and analyzed as in A. E, parallel groups of
human islets of D were labeled with [35S]Met/Cys for 10 min, lysed, immunoprecipitated, and analyzed as C. Newly synthesized A24D from transfected 293T
cells were used as a molecular weight control of uncleaved preproinsulin. F, quantification data of uncleaved preproinsulin in human islets and transfected
293T cells from at least three independent experiments shown in A–E.
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tide-N-glycosidase F), whereas preproinsulin R6C did not
acquire anN-linked glycan at either site (Fig. 3B, lanes 5 and 6).
Thus, translocation of uncleaved R6Cwas not even delivered to
the ER lumen 3–5 residues beyond the end of the SP.
Together, these data establish that, although preproinsulin-
R6C is targeted to the ER, it exhibits impaired polypeptide
translocation across the ER membrane. Untranslocated R6C
remains strongly associated with the ER membranes with its
proinsulin moiety exposed to the cytosol. This is distinct from
the previously characterized preproinsulin-A24D mutant,
which is translocated into the ER lumen and induced ER stress
(12, 13).
The Positive Charge in the N Region and Charge Gradient
Flanking the H Region of the SP Play a Critical Role in Efficient
Targeting and Translocation of Preproinsulin—Mutations R6C
and R6H remove the highly conserved n region positive charge.
To determine the importance of basic residues in the SP n
region formediating targeting and translocation of preproinsu-
lin, we introduced Arg at position 5 to create a M5R/R6C dou-
ble mutant, thereby restoring a positive charge to the n region.
This significantly improved translocation efficiency of R6C,
both in transfected 293T cells (Fig. 4A) and in the reconstituted
in vitro targeting and translocation assay (Figs. 2, A and B).
In general, a positive charge in the SP n region helps to orient
the signal sequence during translocation, with the n region on
the cytosolic side of the ER membrane and the c region of SP
toward the lumen (positive-inside rule) (27, 29). Although the
preproinsulin residue Arg-6 is highly conserved, we noted that
a negative charge in the c region of human preproinsulin (resi-
due 20) is not conserved in rodents (Fig. 4B). Indeed, although
human andmousewild-type preproinsulinwere fully cleaved at
a steady state (Fig. 4C), the R6C mutation in mouse preproin-
sulin exerted an even more deleterious effect on the processing
of preproinsulin in INS1 cells (Fig. 4, C and D; the Myc-tagged
preproinsulin WT and R6C (Fig. 4C, top panel) allowed us to
examine translocation defects of R6C in  cells). Reciprocally,
we created a double mutant, R6C/D20R, in which the charge
gradient flanking the h region of the human preproinsulin sig-
nal sequence was reversed. R6C/D20R exhibited dramatically
reduced translocation by both pulse labeling (Fig. 4E) and
steady-state measurements (Fig. 4, F and G). Together, these
data indicate that the charge gradient flanking the h region of
the signal sequence plays a critical role in the translocation of
preproinsulin.
R6C Does Not Affect Coexpressed Preproinsulin WT nor
Induce ER Stress—We examined insulin production derived
from thesemutants in INS1 (rat)  cells using a human-specific
insulin radioimmunoassay (13, 30). INS1 cells transfected with
human preproinsulin R6C produced and secreted about half as
much human insulin as the WT (Fig. 5A), consistent with the
results above (Figs. 1–4) showing that50% of R6Cmolecules
are translocated into the ER. However, this partial defect alone
is insufficient to account for insulin-deficient diabetes (31).
Given that R6C and R6H are associated with autosomal domi-
FIGURE 2. Preproinsulin R6C and R6H are targeted to and strongly asso-
ciatedwith theERmembranebutexhibit impaired translocation.AandB,
effect of R6C on SRP-dependent protein targeting and translocation in vitro.
Preproinsulin WT andmutants were synthesized by in vitro translation in the
presence of [35S]Met. The ability of exogenously added SRP and SRP receptor
to target preproinsulins to salt-washed and trypsin-digested ER microsomes
(TKRM) was assayed by cleavage of the SP upon successful translocation (A)
and by protection of the translocated protein from PK digestion (B), as
described under “Experimental Procedures.” The translocation efficiency of
themutantproteinswasnormalized to thatofpreproinsulinWT,whose trans-
location at saturating SRP receptor concentration was set to be 100%. C, pre-
proinsulin (preProins) R6C is targeted to themicrosomes in anSRP-dependent
manner. In vitro synthesis, targeting, and translocation of preproinsulin WT
and R6C were carried out as in A and B in the presence and absence of exog-
enously added SRP and rough microsomes (RM). The reactions were loaded
on a 0.5 M sucrose cushion, andmicrosomalmembraneswere sedimented by
ultracentrifugation as described under “Experimental Procedures.” S, super-
natant; P, pellet; Proins, proinsulin. D, quantification of data from two inde-
pendent experiments shown inC. E, 293T cells coexpressingpreproinsulinWT
or mutants with a separate CMV promoter-driven GFP expressed in the cyto-
sol were labeled with [35S]Cys/Met for 15 min and then incubated with or
without 0.01% digitonin in PBS for 10 min to selectively permeabilize the
plasma membrane. The cells transfected with empty vector (EV) served as
controls. The membrane-bound and luminal proteins were sedimented at
14,000 rpm for 10 min. In digitonin-treated cells, although the majority of
cytosolic GFP was liberated into supernatant, both cleaved and uncleaved
preproinsulin remained in the pellet. IP, immunoprecipitation. F, 293T cells
expressingpreproinsulinR6CandA24Dwere labeledwith [35S]Cys/Met for 20
min and subjected to the carbonate extraction as described under “Experi-
mental Procedures.” Althoughproinsulin derived fromR6Cwasmostly recov-
ered in the supernatant (S) along with BiP, the majority of uncleaved prepro-
insulin R6C and A24D remained in the membrane pellet (P) along with
calnexin, suggesting that uncleavedpreproinsulinmutants are strongly asso-
ciated with the ER membrane. T, total lysate.
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nant diabetes (14–16), it was important to knowwhether these
mutants behave like those causing the syndrome of MIDY,
which exert dominant-negative effects on the folding/stability
and trafficking of coexpressed proinsulinWT (9, 13, 30). To test
this, we coexpressed untagged preproinsulin WT with either
Myc-tagged preproinsulin WT, R6C, or A24D. We found that,
unlike Myc-tagged A24D (which blocks the secretion of coex-
pressed proinsulinWT, Fig. 5B, lanes 13–15), Myc-tagged R6C
did not inhibit the expression, translocation, or processing
of coexpressed untagged preproinsulin WT (Fig. 5B, lanes
10–12). Thus, Arg-6 mutants behave very differently from
MIDY mutants described previously (9, 10).
Using GFP-tagged preproinsulin constructs, a recent study
reported no defect of R6C/R6H in the targeting of preproinsu-
lin to insulin granules but suggested that ER stress might con-
tribute to  cell death and diabetes in patients carrying these
mutations (14). Importantly, fusionwithGFP (238 amino acids)
triples the length of preproinsulin (110 amino acids) that may
alter (increase) translocation efficiency (32–34). Therefore, we
compared the translocation efficiency of R6Cwith either a GFP
tag or a Myc tag in the C peptide. In both pulse labeling and
Western blotting experiments, althoughMyc-tagged preproin-
sulin WT, A24D, and R6C all appeared identical to their
untagged counterparts (Fig. 5C, top and center panels), GFP-
tagged R6C showed no detectable translocation defect (Fig. 5C,
bottom panel, with A24D serving as a positive control for the
mobility of the uncleaved precursor).Next, we examined the ER
stress response in INS1 cells expressing Myc-tagged preproin-
sulinWT,R6C, orA24Dusing aBiP promoter-driven luciferase
reporter (9). We found that, unlike A24D, R6C did not induce
an activation of the BiP promoter (Fig. 5D). Together, these
data suggest that larger secretory polypeptides may be insensi-
tive to the effects of the R6Cmutation. Thus, GFP-tagging may
confound studies of the translocation of small secretory
proteins.
Untranslocated PreproinsulinAccumulates in a Juxtanuclear
Compartment, Induces HSP70 Expression, and Promotes  Cell
Death—To understand the pathological consequences of the
translocation defects of R6C, using INS-r9 cells carrying the
reverse doxycycline-dependent transactivator (22), we estab-
lished  cell lines in which expression of Myc-tagged mouse
preproinsulin WT, R6C, or A24D was induced in the presence
of doxycycline. TheMyc epitope tag in the C peptide allowed for
unequivocal distinction of these constructs fromendogenous pre-
proinsulin and proinsulin (13). Pulse labeling and Western blot-
ting experiments showed that these cell lines exhibited compara-
ble levels of induced expression ofWT and R6C (Fig. 6, A and B).
We then examined the localization ofMyc-taggedmouse prepro-
insulin WT and mutants in these cell lines by immunofluores-
cence. Cells were pretreated with cycloheximide to minimize the
contribution of newly synthesized molecules. Expression of pre-
proinsulin WT led to an insulin granule-like pattern that was
mostly concentrated in the distal tips of cellular processes (arrow-
heads), distinct from the ER marker PDI (Fig. 6C, top row). By
contrast, expression of A24D led to a localization pattern that
largely overlapped with PDI (Fig. 6C, center row). Interestingly, in
addition to weak ER staining, two major intracellular pools accu-
mulated for R6C: one concentrated normally in granules at the
distal tips of cellular processes (Fig. 6C, arrowheads), whereas
another concentrated abnormally as punctate structures at a jux-
tanuclear location (Fig. 6C, arrows). Neither structure overlapped
with PDI (Fig. 6C, bottom row).
To further explore the juxtanuclear accumulation, parallel
wells of the inducible cells used in Fig. 6C were partially per-
meabilized with 0.01% digitonin, fixed, and processed for anti-
GM130 (a Golgi marker) and anti-Myc immunofluorescence
(Fig. 7A). In partially permeabilized cells, anti-Myc immuno-
fluorescence was detected only for R6C in a region near the
Golgi complex (Fig. 7A, bottom row), suggesting that the proin-
sulin moiety of untranslocated R6C was exposed in the cytosol.
FIGURE 3. The proinsulin moiety of preproinsulin R6C is exposed to the cytosol. A, 293T cells expressing Myc-tagged preproinsulin (preProins) R6C and
A24D were subjected to PK digestion in the presence or absence of digitonin (DIG) or Triton X-100 (TRX), followed by anti-Myc Western blotting as described
under “Experimental Procedures.” Unprocessed R6Cwas sensitive to PK digestion in partially permeabilized cells, indicating that its proinsulin (Proins) moiety
was exposed to the cytosol. B, two engineered human preproinsulins with N-linked glycosylation sites were created, as indicated in the top panel. The newly
synthesized preproinsulin WT and R6C labeled with either [35S]Met or [35S]Cys/Met were treated with or without PNGaseF before SDS-PAGE. Although
proinsulinderived fromWTorR6Cwasglycosylated (glyco-proins, lanes 3,7,9, and11), unprocessedR6C labeledbypure [35S]Met (lanes 5and6) failed toacquire
an N-linked glycan, indicating that unprocessed R6C was not delivered to the ER lumen.
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To examine whether R6C accumulates in the Golgi, we dis-
rupted the Golgi structure using brefeldin A. The juxtanuclear
accumulation persisted even after the Golgi architecture was
disrupted (Fig. 7B). These data indicate that a large subpopula-
tion of incompletely translocated R6C molecules relocates
from the ER and accumulates in a novel cytoplasmic compart-
ment, with its proinsulin moiety exposed to the cytosol.
Accumulation of juxtanuclear puncta has been observed
upon induction of proteostasis stress in the cytosol (35, 36).
Therefore, we asked whether accumulation of R6C analogously
induces cellular responses and, if so, in which subcellular com-
partment. Consistent with Fig. 5D, markers of the ER-associ-
ated unfolded protein response, including BiP and eIF2 phos-
phorylation, were comparable between cells expressing
preproinsulin WT and R6C (Fig. 7, C, E, and F). In contrast,
expression of R6C induced enhanced expression of HSP70 (Fig.
7, C and D), indicating activation of a cytosolic response.
Because juxtanuclear accumulation of misfolded protein has
been linked to cell death in neurodegenerative diseases (37, 38),
we asked whether accumulation of preproinsulin R6C affects
cell viability and proliferation. No appreciable change of BrdU
incorporation was observed between cells expressing Myc-
tagged preproinsulin WT and R6C (Fig. 7G), suggesting that
R6C did not affect  cell proliferation. However, after a 4-day
induction of preproinsulin expression, there was a significant
increase of cell death in  cells expressing R6C (Fig. 7H).
Together, the data indicate that incompletely translocated R6C
accumulates in a juxtanuclear compartment, induces a cytosol-
FIGURE 4. The positive charge in the n region and the charge gradient flanking the h region of the SP play a critical role in the efficient targeting and
translocation of preproinsulin. A, 293T cells transfected with empty vector (EV), human preproinsulin (preProins) WT, R6C, or M5R/R6C were labeled with
[35S]Cys/Met for 15 min and analyzed by SDS-PAGE. Proins, proinsulin. B, the homology of human and rodent insulin gene 2 (Ins2) preproinsulin signal
sequences. C, INS1 cells expressing Myc-tagged human (Hu) preproinsulin WT or R6C or mouse (Mo) Ins2 WT or R6C were examined by anti-Myc Western
blotting (WB). Mouse Ins2 R6C shows amore severe translocation defect than human R6C.D, quantification data of uncleaved preproinsulin fromat least three
independent experiments shown inC. E, INS1 cells expressingMyc-taggedhumanpreproinsulinWTormutantswere labeledwith [35S]Met/Cys for 10min. The
newly synthesized preproinsulin was immunoprecipitated (IP) with anti-Myc, followed by SDS-PAGE. F, Myc-tagged human preproinsulin WT or mutants in
transfected INS1 cells were examined by anti-MycWestern blotting. R6C/D20R significantly exacerbated the defect of R6C.G, quantification data of uncleaved
preproinsulin from at least three independent experiments shown in F.
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ic response, and promotes  cell death through mechanisms
distinct from those reported previously for A24D and other
MIDY mutants (Fig. 8).
DISCUSSION
In pancreatic  cells, a multistep process lasting 30–150min is
needed to synthesize mature insulin (1, 39), yet the earliest events
at the point of entry of preproinsulin into the ER remain under-
studied.Herewe demonstrate that the SPn region positive charge
plays an important role in ensuring efficient translocation of pre-
proinsulin across the ERmembrane and that inefficient preproin-
sulin translocation contributes to  cell failure and diabetes.
Unlike most MIDY patients developing early-onset diabetes,
patients carrying the R6C and R6H SP mutations develop non-
obese autosomal dominant diabetes between 15–65 years of
FIGURE 5. R6C and R6H fail to produce a normal amount of insulin but do not affect coexpressed preproinsulin WT nor induce ER stress. A, INS1 cells
were transfectedwith empty vector (EV), humanpreproinsulinWTormutants. At 48hpost-transfection, thehuman insulin in the lysates (black bars) andmedia
(white bars) were measured using human insulin-specific RIA normalized to human insulin mRNA. Results shown are mean  S.D. from three independent
experiments. *,p0.05 comparedwithpreproinsulinWT.B, 293T cellswere cotransfectedwithuntaggedpreproinsulin (preProins)WT,with empty vector (EV),
orMyc-taggedpreproinsulinWT, ormutants. At 48 hpost-transfection, the cellswere labeled for 15min, followedby a 0- or 3-h chase. Cell lysates (C) and chase
media (M) were immunoprecipitatedwith anti-insulin and analyzed under reducing conditions. Unlike A24D, which blocked the secretion of coexpressedWT,
R6C did not affect the expression, translocation, and secretion of coexpressedWT. Proins, proinsulin. C, the plasmids encoding human preproinsulin WT, R6C,
or A24Dwith or without a Myc or GFP tag was transfected into 293T or INS1 cells as indicated. The cells transfected with empty vector (EV) served as controls.
After 48 h post-transfection, the expression and SP cleavage of untagged or tagged preproinsulin were examined and compared by pulse labeling (newly
synthesized) and Western blotting (steady state) using anti-insulin, anti-Myc, or anti-GFP antibodies, as indicated. Unlike untagged and Myc-tagged prepro-
insulin R6C, there was no detectable defect in GFP-tagged R6C. IP, immunoprecipitation; aa, amino acids. D, BiP promoter activities in transfected pancreatic
 cells were evaluated as described under “Experimental Procedures.” Cells expressing preproinsulin WT were served as a control. Results were expressed as
mean S.D. from at least three independent experiments. *, p 0.05 compared with preproinsulin WT.
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age (14–16), suggesting that these mutants may cause diabetes
via a distinct mechanism. In this report, we examined the bio-
logical behaviors of these two preproinsulin mutants. The evi-
dence presented here strongly suggests that inefficient prepro-
insulin translocation is responsible for  cell failure in patients
carrying thesemutations. AlthoughR6CandR6Hmutations do
not appear to affect SRP-dependent targeting to the ER (Fig.
2C), only a subpopulation of R6Cmolecules is translocated suc-
cessfully into the ER lumen, as judged by processing to proin-
sulin (Figs. 1–3) or insulin (Fig. 5A), whereas the other major
subpopulation remains as uncleaved preproinsulin. Uncleaved
R6Cdoes not access the oxidizing environment of the ER lumen
(Fig. 1C), is sensitive to PK digestion in partially permeabilized
cells (Fig. 3A), cannot deliver an acceptor sequence for luminal
FIGURE 6. Untranslocated R6C accumulates in a juxtanuclear region in pancreatic  cells. A, INS1 cells inducibly expressing Myc-tagged mouse prepro-
insulin (preProins) WT or mutants were established as described under “Experimental Procedures.” After Dox induction for the indicated days, the newly
synthesized endogenous proinsulin (Proins), Myc-tagged preproinsulin WT, and R6C of inducible cell lines were labeled with [35S]Met/Cys for 15 min, immu-
noprecipitated with anti-insulin, and analyzed under reducing conditions. B, the steady state of Myc-tagged preproinsulin WT and R6C from the same sets of
cells as in Awas detected by anti-MycWestern blotting. C, after 4 days of Dox induction, INS1-inducible cell lines expressingMyc-taggedmouse preproinsulin
WT, R6C, or A24D were pretreated with cycloheximide for 1 h before being fully permeabilized with 0.5% Triton X-100 and immunostained with anti-Myc
(green) and anti-PDI (an ER marker, red) antibodies. Nuclei were counterstained with DAPI. In most cells expressing Myc-tagged preproinsulin WT (top row),
anti-Myc immunoreactablemolecules presented as a punctate, insulin granule-like pattern (arrowheads) that was distinct from PDI. For R6C (bottom row), two
major intracellular pools were observed. One did indeed concentrate in distal tips (arrowheads), whereas another accumulated in a juxtanuclear region
(arrows), and neither pool overlapped with PDI. A24D lost the granule pattern and largely overlapped with PDI.
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N-glycosylation (Fig. 3B), and can be detected by antibodies in
the cytosol (Fig. 7, A and B). Thus, by multiple independent
measures, we demonstrate that amajor subpopulation of R6C is
not translocated into the ER.
Upon arrival at the ER membrane, the SP interacts with the
Sec61 translocon through which the SP (or signal anchor of
membrane proteins) becomes properly oriented and processed
in the membrane (40–42) according to the positive-inside rule
FIGURE 7. Intracellular accumulationof untranslocatedR6C induces cytosolic stress andpromotes cell death.A, the plasmamembranes of similar sets
of INA1-inducible cell lines as in Fig. 6Cwere selectively permeabilized by 0.01% digitonin and immunoblotted with anti-Myc (green) and anti-GM130 (a Golgi
marker, red) antibodies. Nuclei were counterstained with DAPI. Unlike in Fig. 6C, anti-Myc immunoreactable molecules were detected only in the cells
expressingMyc-tagged R6C, indicating that the proinsulinmoiety of untranslocated R6Cwas exposed to the cytosol. Suchmolecules appeared to accumulate
in a juxtanuclear region close to the Golgi marker GM130. B, parallel wells of the cells expressing Myc-tagged R6C as in Awere pretreated with 5M brefeldin
A (BFA) for 30min todisrupt theGolgi structurebeforebeingpartially permeabilizedand immunoblottedas inA. The juxtanuclear accumulationpersistedeven
after the Golgi architecture was disrupted by brefeldin A. C, the expression of HSP70, BiP, total eIF2a (eIF2a-T), and phosphorylated eIF2 (eIF2-P) in INS1
inducible cell lines were examined byWestern blotting after Dox induction the indicated days. The INS1 cells treatedwith 10M tunicamycin for 6 h served as
controls.D–F, quantification data of HSP70, eIF2-P, and BiP from two to four independent experiments shown C.G, BrdU incorporation of INS1-inducible cell
lines after 4 days of Dox induction ofMyc-taggedWTor R6C expressionwasmeasured as described under “Experimental Procedures.”H, cell death of the same
sets of cells as in Gwas detected using TUNEL as described under “Experimental Procedures.” A total of4500 cells expressingWT or R6Cwere counted from
three independent experiments. The cells in parallel wells treated without Dox were used as controls. Results are shown as means  S.D. from three inde-
pendent experiments. *, p 0.05 compared with Myc-tagged preproinsulin WT.
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(43, 44). We hypothesize that loss of the Arg-6 positive charge
impairs the ability of the n region to orient the preproinsulin SP
within the Sec61 translocon, resulting in misorientation of 50%
of themolecules during translocation (Fig. 8). In support of this
idea, restoring a positive charge to the SP n region significantly
alleviates the translocation defect of R6C (Figs. 2, A and B, and
4A), whereas adding positive charge to the c region of R6C
exacerbates the translocation defect (Fig. 4, C–G). In addition,
under physiological pH, histidine is partially protonated, which
may explain the difference in severity of the translocation
defect of R6C and R6H (Fig. 1,B,C, and F). Together, these data
strongly suggest that the charge gradient flanking the SP h
region helps to guide the orientation of the preproinsulin signal
sequence, thereby regulating the efficiency of preproinsulin
translocation and insulin production.
Intriguingly, the importance of the n region positive charge
in properly orienting the SP and mediating translocation
appears to be dependent on the length of the substrate proteins.
By comparing untagged and small Myc-tagged preproinsulin
with GFP-tagged preproinsulin, we found that the defect
caused by loss of the SP n region positive charge occurred only
in Myc-tagged and untagged preproinsulin (Fig. 5C). Recently,
several studies show that small secretory proteins constitute a
great fraction of the proteome than previously estimated, and
they may depend more on posttranslational mechanisms for
efficient translocation (32–34, 45–47). Preproinsulin is a small
secretory protein, so preproinsulin fusedwithGFP significantly
increases the length of the polypeptide andmay alter the trans-
location efficiency/pathway preproinsulin takes in cells. There-
fore, GFP tagging is likely unsuitable for studying the translo-
cation of preproinsulin. The dependence of other small
secretory proteins on the SP n region positive charge for their
efficient translocation remains to be determined.
It has been shown that insulin gene mutations causing low
gene expression are recessive, rather than dominant, causes of
diabetes (31). Therefore, for R6C or R6H, a 50% reduction in
insulin production alone (Fig. 5A) cannot explain dominant
diabetes in heterozygous patients. In the autosomal dominant
syndrome of MIDY, mutant (pre)proinsulins such as preproin-
sulin A24D cause  cell failure and diabetes by abnormally
interacting with coexpressed wild-type proinsulin in the ER,
impairing folding and ER export of wild-type proinsulin, lead-
ing to insulin deficiency (9, 12, 13, 30), and triggering ER stress
and early-onset diabetes (13, 48, 49). However, R6C and R6H
cause late-onset diabetes, suggesting that they do not follow the
MIDY model described previously. Indeed, our data indicate
that, although newly synthesized uncleaved A24D and R6C
are both targeted to and strongly associated with the ER mem-
brane (Fig. 2), the proinsulin moiety for these two mutants is
exposed on opposite sides of the ERmembrane (Fig. 3A).More-
over, R6C does not affect the expression, translocation, or
intracellular trafficking of coexpressed (pre)proinsulin WT
(Fig. 5B).
Because defective R6C molecules do not enter the ER lumen
(Figs. 1–3, 6C, and 7A), R6C does not induce appreciable ER
stress (Figs. 5D and 7C). Instead, untranslocated R6C accumu-
lates in a juxtanuclear compartment that is distinct from the
Golgi complex in  cells (Figs. 6C and 7, A and B). Accumula-
tion of juxtanuclear puncta has been observed upon expression
of misfolding- and aggregation-prone proteins in the cytosol
that induces cytoplasmic proteostasis stress (35, 36). Im-
portantly, cytosolic/juxtanuclear accumulation of misfolded
and/or mislocalized proteins has been linked to cell death that
contributes to the development and progression of multiple
neurodegenerative diseases, including Huntington, Parkinson,
Alzheimer, and prion disease (35, 37, 38, 50–55). Analogously,
here we find that expression of R6C and its cytoplasmic/jux-
tanuclear accumulation strongly correlates with a cytosolic
response and  cell death (Figs. 6 and 7). Thus, our findings
establish a novel molecular pathogenesis of pancreatic  cell
FIGURE 8.A proposedmodel of cell failure and diabetes caused by the defects in the earliest events of insulin biosynthesis. Two distinct underlying
mechanisms associated with the defects occurring at the ER membrane can lead to  cell failure and diabetes. For preproinsulin A24D, impaired SP cleavage
causes preproinsulin misfolding in the ER. Misfolded A24D not only induces ER stress but also blocks coexpressed proinsulin WT exit from the ER, causing a
decrease of insulin production from proinsulinWT, leading to early-onset diabetes. For R6C, loss of the positive charge in the preproinsulin SP n region results
in amisorientation of about 50% newly synthesized R6Cmolecules when their signal sequences interact with the Sec61 translocon. Themisoriented R6C fails
to be translocated into the ER lumen, accumulates in the cytosol and juxtanuclear compartment, induces cytosolic stress, and leads to  cell death and
late-onset diabetes.
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failure and diabetes distinct frommechanisms described previ-
ously (Fig. 8).
Integrating these findings, we speculate that inefficient
translocation of preproinsulin might have implications for dia-
betes even in the absence of INS gene mutations. Certainly in
neurons, inefficient translocation of thewild-type prion protein
precursor can trigger neurodegeneration (52, 56–58).With this
in mind, it is important to note that insulin biosynthesis alone
accounts for more than 10% of total protein synthesis under
basal condition in  cells. This percentage can further increase
to 30–50% upon high glucose stimulation (59, 60), and up-reg-
ulated preproinsulin production can occur in both type 1 and
type 2 diabetes (61, 62). Given the fact that a small fraction of
fully translated newly synthesized preproinsulin is present in
the cytosol in normal human islets (Fig. 1, D–F) and that R6H
with a less severe translocation defect can cause diabetes, there
is the possibility that untranslocated preproinsulin WT can
become a dangerous byproduct under certain pathological con-
ditions. Studies are now needed to examine the efficiency of
preproinsulin translocation in  cells in “garden variety” type 1
and type 2 diabetes.
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